Neal Shirey, MD
Vascular & Interventional Radiology · Griffin, GANPI 1992764690
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $22,260 of the $26,433 with a category attached, or 84.2%. Cardiovascular Systems Inc. accounts for 74.0% of it on its own, with 16 other manufacturers making up the rest. Reporting peaked in 2022 at $10,280 and has fallen 97.1% since, to $300 in 2025.
Across 135 payments — averaging $195.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Cardiovascular Systems Inc.$20K
- Abbott$5K
- Endologix LLC$669
- Angiodynamics, Inc.$419
- Veryan Medical Incorporated$147
- Penumbra, Inc.$116
- plus $302 from 11 others
What the payments were for
- Speaking & faculty fees$22,26084%
- Travel & lodging$6923%
- Food & beverage$3,25012%
- Education$2301%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Cardiovascular Systems Inc. | 56 | $19,573 |
| Abbott | 47 | $5,206 |
| Endologix LLC | 9 | $669 |
| Angiodynamics, Inc. | 7 | $419 |
| Veryan Medical Incorporated | 1 | $147 |
| Penumbra, Inc. | 1 | $116 |
| Cardiva Medical, Inc. | 1 | $71 |
| Johnson & Johnson | 4 | $66 |
| Siemens Medical Solutions USA, Inc. | 1 | $39 |
| Cordis US CORP. | 1 | $26 |
| Bard Peripheral Vascular, Inc. | 1 | $18 |
| W. L. Gore & Associates, Inc. | 1 | $17 |
| BD | 1 | $14 |
| Biotronik Inc. | 1 | $13 |
| Nevro Corp. | 1 | $13 |
| Medtronic | 1 | $13 |
| Cook Medical LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$26,433 in reported general payments places this provider in the 85th percentile of 120 vascular & interventional radiology providers in Georgia.
See all vascular & interventional radiology providers in Georgia →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 24 | $17,225 |
| ClopidogrelClopidogrel Bisulfate | 124 | $1,198 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 17 | $93 |
Paid to pharmacies, not to this prescriber.
Other vascular & interventional radiology in Griffin
- Nima KokabiAtlanta$1M
- Jason LevyAtlanta$822K
- Aravind ArepallyAtlanta$249K
- Kei YamadaAtlanta$154K
- Charles TeeslinkAugusta$135K
- Kirema Garcia-ReyesAtlanta$115K
- Roger WilliamsMarietta$100K
- John PrologoAtlanta$97K
- Jonathan MartinAtlanta$82K
- Steven CitronAtlanta$66K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.